PROTEOLYSIS TARGETING CHIMERA (PROTACS) AS DEGRADERS OF SMARCA2 AND/OR SMARCA4

Alessio Ciulli (Inventor), Christian Dank (Inventor), Emelyne Diers (Inventor), William Farnaby (Inventor), Michael Roy (Inventor), Steffen Steurer (Inventor), Nicole Trainor (Inventor)

Research output: Patent

Abstract

The present invention encompasses compounds of formula (I) wherein the groups R1, A, G, LK and t have the meanings given in the claims and specification, their use as degraders of SMARCA2 and/or SMARCA4, pharmaceutical compositions which contain compounds of this kind and their use as medicaments/medical uses, especially as agents for treatment and/or prevention of oncological diseases.
Original languageEnglish
Patent numberWO/2020/078933
Priority date16/10/18
Filing date14/10/19
Publication statusPublished - 23 Apr 2020

Fingerprint

Dive into the research topics of 'PROTEOLYSIS TARGETING CHIMERA (PROTACS) AS DEGRADERS OF SMARCA2 AND/OR SMARCA4'. Together they form a unique fingerprint.

Cite this